TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Page 1 of 10
`
`To:
`
`Subject:
`
`Rogue Valley Natural Springs, Inc. (nancy@chernofflaw.com)
`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Sent:
`
`5/26/2007 7:58:05 PM
`
`Sent As:
`
`ECOM1 l4@USPTO.GOV
`
`Attachments: Attachment - 1
`
`Attachment - 2
`
`Attachment - 3
`
`Attachment - 4
`
`Attachment - 5
`
`Attachment - 6
`
`Attachment - 7
`
`Attachment - 8
`
`Attachment - 9
`
`Attachment - 10
`
`Attachment - 11
`
`Attachment - 12
`
`Attachment - 13
`
`Attachment - 14
`
`Attachment - 15
`
`Attachment - 16
`
`|!mp0rtant Email Information]
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`SERIAL NO:
`
`78/696803
`
`,
`
`APPLICANT:
`
`Rogue Valley Natural Springs, Inc.
`
`CORRESPONDENT ADDRESS:
`NANCY J. MORIARTY
`
`CHERNOFF VILHAUER MCCLUNG & STENZEL, LLP
`601 SW 2ND AVE STE 1600
`
`PORTLAND, OR 97204-3157
`
`MARK:
`
`EYEIVIIST
`
`CORRESPONDENT’S REFERENCE/DOCKET N0: 8173.0023
`
`CORRESPONDENT EMAIL ADDRESS:
`‘
`nanc
`chernofflaw.com
`
`RETURN ADDRESS:
`Commissioner for Trademarks
`
`PO BOX 1451
`Alexandria, VA 22313-1451
`
`Ifno fees are enclosed. the address should
`include the words "Boo: Responses -No Fee."
`
`Please provide in all correspondence:
`
`1. Filing date, serial number, mark and
`app licant's name.
`2. Dale of this Office Action.
`3. Examining Anomcy's name and
`Law Oflice number.
`4. Your telephone number and e-mail
`address.
`
`file://\\ticrs-ais-01\ticrsexport\HtmlToTifflnput\REC000 12007_05_30_15_42_1 l_TTABO . ..
`
`5/3 0/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8l73.0023
`
`Page 2 of 10
`
`Serial Number 78/696803
`
`The trademark examining attorney has carefully reviewed the request for reconsideration and is not
`persuaded by applicant’s arguments. No new issue has been raised and no new compelling evidence has
`been presented with regard to the point(s) at issue in the final action. TMEP §71S.03(a). Therefore, the
`request for reconsideration is denied and the final refusal(s) under Section 2(e)(l) is continued. 37
`C.F.R. §2.64(b); TMEP §715.o4.
`
`While the applicant argues that most of the evidence references the applicant’s goods, the evidence is
`precisely relevant because the determination of whether a mark is merely descriptive is considered in
`relation to the identified goods, not in the abstract. See In re Abcor Dev. Corp., 588 F.2d 811, 814, 200
`USPQ 215, 218 (CCPA 1978); see, e.g., In re Polo Int'l Inc., 51 USPQ2d 1061 (TTAB 1999) (DOC in
`DOC-CONTROL would be understood to refer to the “documents” managed by applicant's sofiware,
`not “doctor” as shown in dictionary definition); In re Digital Research Inc., 4 USPQ2d 1242 (TTAB
`1987) (CONCURRENT PC-DOS found merely descriptive of “computer programs recorded on disk”
`where relevant trade uses the denomination “concurrent” as a descriptor of this particular type of
`operating system); see TMEP §l209.0l(b).
`
`information generically uses the word MIST to identify its goods.
`The applicant’s own product
`According to the applicant, “[f]or maximum benefit,
`the eye mist must be correctly applied.”
`http://www.naturestea1s.corn/articles/article Q13; Eyephp.
`See
`attached.
`Emphasis
`added. The
`directions for using the products remind the user that “. .. only a minuscule amount of mist must enter
`your eyes for Nature’s Tears EyeMist to be effective.”
`httpI//WWW.bi0l0giCagua.Com/store/index.2hp?main page=index&cPa1h=1.
`added.
`Further on-line product information informs us that:
`
`See attached. Emphasis
`
`The water's purity and mild mineral content make it ideal as a tissue-cu1tu.re medium in
`biologic laboratory experiments and as a moisturizing mist for eyes.
`
`I NATURE'S TEARS® is an all-natural moisturizing mist for the eyes developed with
`the consulting assistance of Dr. William Mathers,
`from Oregon "S‘i§ieri"ces:{';
`University's Casey Eye Institute. Dr. Mathers' study of NATURE'S TEARS® (2000) and“
`dry eye patients showed, on average, that the mist doubled the moisture volume of the
`eyes‘ tear film without disrupting the tear film's delicate structure. Contact lens wearers
`were the most enthusiastic. The mist creates a micro-environment of pure, all-natural,
`unpolluted, pH correct humidity around the face.
`
`See
`http://www.medcompa.re.com/details/3 1914/Nature's-TearsAndreg-EyeMistAndtrade.html.
`attached. Emphasis added.
`Instead of eye drops, the goods are eye mists. The fact that the product is a
`mist rather than eye drops or the like is immediately conveyed by the mark, because the mark EYEMIST
`conveys with no uncertainty that the goods are mists for eyes. No thought or imagination is required to
`determine the nature of the goods. The applicant’s website discusses the advantages of using eye mists
`over eye drops:
`
`Benefits of ocular misting.
`
`o Instantly soothes dry imitated eyes.
`o Convenient and easy to apply (even if your hand is unsteady).
`
`file ://\\ticrs-ais-0 1\ticrsexp ort\Htrn1ToTifflnput\REC000 l2007_0 5_3 0_1 5_42_l l_TTABO . ..
`
`5/3 0/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Page 3 of 10
`
`o No touching of eyelids, tilting back of head or aiming of dropper.
`o Misting supplies only what eyes need
`o Does not flood ocular tear film or interfere with tear film structure.
`
`o Moisturizes contact lenses without removing lenses.
`0 Soothes computer eye strain (also called "Computer Vision Syndrome" or CVS).
`o No additives, chemicals, preservatives or propellants.
`0 Will not smudge eye make-up.
`0 May also be used as an emergency eye wash.
`Correct application.
`
`0 The most common error is attempting to apply the mist as though it was an eye drop, by
`aiming it directly intothe eyes. This can flood the eyes and negate some of tlie benefit.
`http://www.naturestears.com/articles/article E Eyephp. See attached. Emphasis added.
`
`The applicant’s website describes the misting technology as “cutting-edge.” Even if the applicant is the
`first to invent eye mists as an advancement of traditional eye drops and to call such goods EYEMIST,
`the fact that an applicant may be the first and sole user of a merely descriptive or generic designation
`does not justify registration where the evidence shows that the term is merely descriptive of the
`identified goods and/or services.
`In re Acuson, 225 USPQ 790 (TTAB 1985)
`(COMPUTED
`SONOGRAPHY descriptive of ultrasonic imaging instruments); In re National Shooting Sports
`Foundation, Inc., 219 USPQ 1018 (TTAB 1983) (SHOOTING, HUNTING, OUTDOOR TRADE
`SHOW AND CONFERENCE held apt descriptive name for conducting and arranging trade shows in
`the hunting, shooting and outdoor sports products field); TMEP §1209.03(c).
`
`While applicant argues there is no competitive need for others to call their goods EYEMIST, the
`attached LEXIS articles and on-line articles demonstrate that others do use mists as the means for
`
`administering eye care preparations. Several LEXIS articles even use “eye mist” generically. Thus,
`there is a competitive need for those making eye solutions in mist form, rather than as gels, creams,
`lotions or drops, to call their goods mists and use the word mist. The word EYE merely indicates the
`type or usage of the goods and also must be used by competitors. The combination does not create a
`novel meaning overcoming any descriptive significance.
`
`The Class 3 goods may merely be used for the skin around the users’ eyes, another area that would
`benefit from misting rather than gel or cream application as discussed in Attachements #14-16.
`
`The amount and character of evidence needed to establish acquired distinctiveness depends on the facts
`of each case and particularly on the nature of the mark sought to be registered. See Roux Laboratories,
`Inc. v. Clairol Inc., 427 F.2d 823, 166 USPQ 34 (C.C.P.A. 1970); In re Hehr M12. Co., 279 F.2d 526,
`126 USPQ 381 (C.C.P.A. 1960); In re Gammon Reel, Inc., 227 USPQ 729 (TTAB 1985). More
`evidence is needed where a mark is so highly descriptive that purchasers seeing the matter in relation to
`the named goods and/or services would be less likely to believe that it indicates source in any one party.
`See, eg, In re Bongrain International Corp., 894 F.2d 1316, 13 USPQ2d 1727 (Fed. Cir. 1990); In re
`Seaman & Associates, Inc., 1 USPQ2d 1657 (TTAB 1986); In re Packaging Specialists, Inc., 221 USPQ
`917 (TTAB 1984). However, no amount of purported proof that a generic term has acquired secondary
`meaning can transform that term into a registrable trademark. Such a designation cannot become a
`trademark under any circumstances. See Miller Brewing Co. v. G. Heileman Brewing Co., 561 F.2d 75,
`195 USPQ 281 (7th Cir. 1977), cert. denied, 434 U.S. 1025, 196 USPQ 592 (1978).
`In this case, in View
`of the nature of the mark, the evidence of record is insufficient to establish that the mark EYEMIST has
`acquired distinctiveness for its goods which are in essence eye mists instead of eye drops or eye gels.
`
`The filing of a request for reconsideration does not extend the time for filing a proper response to the
`
`file://\\ticrs-ais-01\ticrsexport\Htm1TOTifflnput\REC000 l2007_05_30_l 5_42_1 1_'ITABO . ..
`
`5/3 0/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Page 4 of 10
`
`final action, which runs from the date the final action was mailed. 37 C.F.R. §2.64(b); TMEP §§715.03
`and 715.03(c).
`
`/Maiy Boagni/
`Examining Attorney
`Law Office 114
`571-272-9130
`Law Office 114 fax: 571-273-9114
`
`Print Request:
`
`Selected Document(s): 2—3,7
`
`Time of Request: Sunday, May 27, 2007
`
`00:05:02
`
`l0083K
`
`Number of Lines: 132
`Print Number:
`2822:29657699
`
`Client ID/Project Name:
`
`Research Information:
`
`LEXPAT;ALL
`EYE MIST
`
`Note:
`
`file://\\ticrs-ais-01\ticrsexport\HtmlToTiffInput\RECO0012007_05_30_15_42_1l_TTABO...
`
`5/30/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Page 5 of 10
`
`Send to:
`
`BOAGNI, MARY
`TRADEMARK LAW LIBRARY
`600 DULANY ST
`ALEXANDRIA, VA 22314-5790
`
`2 of 17 DOCUMENTS
`
`UNITED STATES PATENT AND TRADEMARK OFFICE PRE-GRANT
`PUBLICATION
`
`20070020336
`
`(Note: This is a Patent Application only.)
`
`Link to Claims Section
`
`January 25, 2007
`
`Cyclodextrin nanotechnology for ophthalmic drug delivery
`
`INVENTOR: Loftsson, Thorsteinn — Reykjavik, Iceland (IS), Stefansson, Einar —
`Reykjavik, Iceland (IS)
`
`APPL-NO: 489466
`
`(11)
`
`FILED-DATE: July 20, 2006
`
`ENGLISH-ABST:
`
`The invention provides an ophthalmic composition which is an aqueous
`suspension comprising drug, cyclodextrin and water,
`the composition having an
`aqueous phase of from about 0.1%
`(w/v)
`to about 90% (w/v) of the drug in
`solution, as dissolved free drug and as dissolved drug/cyclodextrin complex(es),
`and a solid phase of from about 10% (w/v)
`to about 99.9% (w/v) of the drug as
`solid drug/cyclodextrin particles, suspended in the aqueous phase;
`the size of
`the solid particles being from about 10 nm to about 1 mm,
`the drug/cyclodextrin
`particles being capable of dissolving in aqueous tear fluid within 24 hours of
`application to the eye surface. The aqueous eye suspension can be in the form of
`eye drops, eye gel or eye mist. Further,
`the invention provides a method for
`treating a condition of the posterior segment and/or anterior segment of the eye
`comprising applying to the eye surface,
`in an amount which delivers to said
`segment or segments a therapeutically effective amount of a drug suitable for
`treating said condition, an ophthalmic composition which is as defined above.
`Nasal compositions and methods and ophthalmic and nasal compositions in powder
`form are also provided.
`
`SUMMARY:
`
`the cyclodextrin comprising at least one natural
`...in aqueous tear fluid,
`cyclodextrin selected from the group consisting of alpha—cyclodextrin,
`beta—cyclodextrin and gamma—cyclodextrin. The aqueous eye suspension can be in
`the form of eye drops, eye gel or eye mist.
`
`file://\\ticrs-ais-01\ticrsexport\Htm1ToTifiInput\REC00012007_05_30_15_42_l l_TTABO . ..
`
`5/30/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173,0023
`
`Page 6 of 10 '
`
`the invention provides a new use for cyclodextrin
`In another aspect,
`[0029]
`in the preparation of an aqueous eye suspension as defined in the preceding
`paragraph, for drug delivery to the posterior segments of the eye in a
`therapeutically ...
`
`DETDESC:
`
`..relatively rapidly in the aqueous tear fluid. Further information relating
`to particle size is shown in Experiment 5 hereinbelow.
`
`[0095] The compositions may further comprise at least one buffer salt and/or
`at least one preservative. The eye drops, eye mist or eye gel,
`that is,
`the
`ophthalmic composition,
`is an aqueous suspension comprising drug, cyclodextrin
`and water,
`the composition having an aqueous phase of from about 0.1 to about
`90%,
`typically about 5 to about 50%, of the drug in solution, as free drug and
`dissolved drug/ ...
`
`...being capable of dissolving in tear fluid within about 24 hours after
`application to the eye surface.
`
`2. The composition according to embodiment 1,
`
`in the form of eye drops.
`
`3. The composition according to embodiment 1,
`an eye gel.
`
`in the form of an eye mist or
`
`4.
`
`The composition according to embodiment 1
`0.25% to about 40% of cyclodextrin.
`
`, 2 or 3, comprising from about
`
`5.
`
`The composition according to embodiment 4, comprising from about 2%
`to about 20% (w/v) of cyclodextrin.
`
`(w/v)
`
`ENGLISH-CLAIMS:
`
`the cyclodextrin comprising at
`...being capable of dissolving in tear fluid,
`least one natural cyclodextrin selected from the group consisting of
`alpha-cyclodextrin, beta—cyclodextrin and gamma—cyclodextrin.
`
`2. The composition according to claim 1,
`mist or an eye gel.
`
`in the form of eye drops, an eye
`
`3. The composition according to claim 1, comprising from about 0.25% to about
`(w/v) of
`409 of cyclodextrin, and further comprising up to about 5%
`(w/v) of metal salts and
`water—soluble polymer, up to about 5%
`
`3 of 17 DOCUMENTS
`
`UNITED STATES PATENT AND TRADEMARK OFFICE PRE-GRANT
`PUBLICATION
`
`20060157064
`
`(Note: This is a Patent Application only.)
`
`Link to Claims Section
`
`July 20, 2006
`
`Apparatus, system and method for treating dry eye conditions
`and promoting healthy eyes
`
`file i//\\ticrs-ais-01\ticrsexport\Htm1ToTifi°Input\REC000 12007_O 5_3 0_1 5_42_1 l_TTABO . ..
`
`5/30/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Page 7 of 10
`
`INVENTOR: Davison, Suzanne - Murrieta, California, United States (US); Paulson,
`Roy - Temecula, California, United States (US)
`
`APPL—NO: 378949
`
`(11)
`
`FILED-DATE: March 16, 2006
`
`ENGLISH-ABST:
`
`An eyewear apparatus for treating dry eye conditions featuring a pair of
`curved eyecups having interior cavities for providing treatment to the eyes when
`worn. Each interior cavity has a sidewall surface adapted to removably engage
`with the perimeter edge of a moisture pad which may be mounted therein to
`provide moisture, aroma, or medicinal
`treatment to the eye. An ocular cavity
`formed in the moisture pads provides a separate treatment chamber to each of the
`two eyes of a user. Heat or cold may also be provided to the ocular chamber
`through temperature components which mount to the moisture pad or in a gap
`between the moisture pad and the front of the interior cavity.
`
`DETDESC:
`
`...each individual eyecup 17 without the addition of a moisture pad.
`
`[0101]
`In another method for adding moisture to the eyecup 17,
`artificial tear solution,
`surface of the eyecup 17 can be sprayed with water,
`spray eye mist,
`for example Biomist,
`or any other solution known in the art,
`before the wearer dons the apparatus of the present invention.
`
`the interior
`
`[0102] Shown in FIG. 15 is another preferred mode of the device shown as a
`sectional view of the moisture pad
`
`7 of 17 DOCUMENTS
`
`UNITED STATES PATENT AND TRADEMARK OFFICE PRE-GRANT
`PUBLICATION
`
`20040167114
`
`(Note: This is a Patent Application only.)
`
`Link to Claims Section
`
`August 26, 2004
`
`Zinc ionophores as therapeutic agents
`
`INVENTOR: Fliss, Henry — Ottawa, Canada (CA)
`
`APPL-NO: 759837
`
`(10)
`
`FILED-DATE: January 16, 2004
`
`ENGLISH-ABST:
`
`The present invention provides methods and compositions comprising one or
`more zinc ionophores for protecting tissue from the harmful effects of apoptosis
`in patients in need thereof. Concentrations of zinc—pyrithione and
`diethyldithiocarbamate in the picomolar to nanomolar range have a strong
`
`file ://\\ticrs-ais-0 1\ticrsexport\HtmlToTifHnput\REC000 12007_05_3 0_l 5_42_1 l_TTABO . ..
`
`5/30/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Page 8 of 10
`
`protective effect against apoptosis.
`
`DETDESC:
`
`...present invention is that the zinc ionophore, e.g. zinc—pyrithione, may be
`administered in-a convenient manner such as by the,
`intravenous,
`intramuscular,
`subcutaneous, oral or intra—cerebroventricular injection routes or by topical
`application, such as in eye drops or eye mist compositions. Depending on the
`route of administration,
`the active ingredients which comprise zinc ionophores
`may be required to be coated in a material to protect the zinc ionophores from
`the action of enzymes, acids and other natural conditions which may inactivate
`the zinc ionophores.
`...
`
`l0O83K
`
`++++++++++ print completed ++++++*+*+
`
`Time of Request: Sunday, May 27, 2007
`
`00:05:02
`
`2822:29657699
`Print Number:
`Number of Lines: 132
`
`Number of Pages:
`
`1
`
`Send To:
`
`BOAGNI, MARY
`TRADEMARK LAW LIBRARY
`
`file ://\\ticrs-ais-01\ticrsexport\Htm1ToTiffInput\REC000 12007_0'g5_30_1 5_42_1 l_TTABO . ..
`
`5/3 0/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Page 9 of 10
`
`600 DULANY ST
`ALEXANDRIA, VA 22314-5790
`
`_
`
`’
`
`3
`:
`
`file ://\\ticrs-ais-01\ticrsexport\Htm1ToTifflnput\REC00O 12007_0 5_30_l5_42_1 l_TTABO . ..
`
`5/3 0/2007
`
`

`
`TRADEMARK APPLICATION NO. 78696803 - EYEMIST - 8173.0023
`
`Page 10 of 10
`
`Note:
`
`In order to avoid size limitation constraints on large e-mail messages, this Office Action has been
`split into 3 smaller e-mail messages. The Office Action in its entirety consists of this message as
`well as the following attachments that you will receive in separate messages:
`
`Email 1 includes the following 7 attachments
`1. appl-1
`app 1-2
`app-1
`app-2
`app3-1
`app3-2
`aromedica-1
`
`>l.°“.V'-.-‘*!~*’!*’
`
`Email 2 includes the following 8 attachments
`1. aromedica-2
`ora-1
`. ora-2
`ora-3
`ora-4
`ora-5
`
`°°.\l?‘!~".-'e°’!‘3
`
`optimyst-1
`. optimyst-2
`
`Email 3 includes the following 1 attachment
`1. optimyst-3
`
`Please ensure that you receive all of the aforementioned attachments, and if you do not, please contact
`the assigned-examining attorney.
`
`file ://\\ticrs-ais-01\ticrsexport\HtmlToTifiInput\REC000 l2007_05_30_1 5_42_1 l_TTABO . ..
`
`5/30/2007
`
`

`
`
`
`
`
`8io~Logic A_qua
`Technologies
`Biomedical Research
`Water and Hydrotherapy "ggg
`
`
`
`
`
`V
`
`Nature‘; “I‘ears® Eye-Mlst
`Nature's Mist®
`Bio-Med Wesh®
`
`
`
`\lature‘s Tearsfé fEy€:Mist.
`
`
`
`
`
`H Search I
`Advanced Search
`
`2
`§
`
`
`
`
`
`
`
`
`
`
`
`
`
`Bestsellers
`
`
`
`§ 1.Nature's Tears
`'
`Eyemist Triple Pack
`2. Nature‘; Tears
`TwlnPox:ir.
`3. Nature‘: Tears
`gygmigt ggngge
`g 4. Club Membership
`
`Nature’: Tear.§® EyeM‘r‘:t® 'forbdfy,_ 'im2atod;qyes.
`
`u 100% Bio-Logic Aquetissue-‘culture -grade water
`0 isafe, sterile and quickly epplfed in a one second sweep.
`o No tear film flooding,
`
`o Preservative and ohernical free,
`-,
`A
`-1- Doubles tear film molsoare
`p. cgntacueng cg]-ngafibkge
`
`o _ Souths 'co;mpute_r eye‘ irritation
`
`New Products ...
`All Products
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Shiopéng & Returns
`Privacy Notlce
`Conditions of Use
`Contact Us
`Gm Cerfifiwta WQ
`Newsletter Unsubscxibe
`
`
`
`
`
`
`
`.o Non allergenic/oreseryative free
`' I No dosage limit»
`
`
`
`
`
`
`
`
`
`
`
`Directions:
`
`with the applicator nozzle poingeditowerqs you, depress ‘the tobof,
`ythe Nature’: TearsvEyeM;s§canIster,,leawngxeyes opened, and must,
`ln 4:, sweeg ~across‘thg‘ eyes for quote tvybo seconds.
`
`Remember that only a ‘rnfnusoule amount of mist rnuit enter your
`eyes for Natunt-.‘s,.Tear,s Ey,eMsst to be effective‘ It Is OK If you blink,
`
`.NI)TE:Nature’s Tears Eye
`ll»-.n<a‘<.
`.
`.
`.
`.
`.
`,
`
`Mist may be ‘applied while wearing contact
`
`
`
`

`
`xrr1
`
`1
`
`yy
`)
`
`‘
`
`“
`
`I
`*
`
`V
`
`.
`
`.‘
`
`A
`
`‘
`
`'
`
`'
`
`.
`
`.,
`"
`
`‘
`
`Displaying 1 to 4 (of 4 products)
`Pmduct Image:
`Product Name‘:-
`
`Nature's Tears
`Evemist Qingie
`
`37.95
`
`add to
`Wcad
`
`Most convenient tin--you can carry it anywhere. Suggested
`applications: Keep In car. pocket. or purse.
`
`
`
`Mature’: Te an
`Twinvack
`
`$14.93
`
`add to
`Weart
`Our twin pack I: by far the most popular choice. You receive two
`10: an: Inside a retail box (lntludas bvodmure with Instructions).
`Urdar Ioday and...
`
`mature’; Tears
`syomiwr Tvifxla Dar-lc
`
`..-=‘....«~....
`c.i7.aLx.}r.s
`
`$20.95
`
`add in
`tag
`
`our value pack give: you a $3 doliar Savingsu Don‘t miss this
`deem You'll save a $1 dollar off each home (when compared to
`purchasing a ¢lnq|a)....
`
`35.00
`
`add to g
`Mcart J
`E9eMi:t_You with Vision Club Membership $1 afdavarv membership
`will he donated to the Save A Child’: Life Faundafion. dedicated to
`the research and...
`
`Your IP Address is: 151.207.2444
`
`Copyright 0 20_05 Bio-Logic Aqua Technologies. Oowerad by Zara Cart
`
`

`
`
`
`medcompare“ n..m..W4.W..wm.m,..
`
`ophfiwaimoiogy
`
`Pmxmczs.
`
`Raw Products
`
`Hews /
`
`'x!x<tems.... .
`
`Jzmrnampdates ...
`
`.. Artistes 7;}
`
`Resources;
`
`Jiuents .
`
`CME£CE;-....\
`
`
`
`A “cm: > Ophihalmotogy > Artificial Tau-5 and Oinhncnb > Nature's ‘l'ears® £yeMist""
`$%?3*"~'¥9V M€é€5C0n‘Pm‘8
`,
`Em“ K‘ ‘Mat; 1
`|%0-V W
`.,..,,...
`.
`- ww
`..,...,..w..-.w.W. W..W_.»._._.,...V,..,...,‘.-..w..w...,,_W...,,.M..w..,..-.._....-._...w
` , Nature's T8flI“S® EVOMISV"
`
`
`
`
`
`” 1,“ ‘mm 0",“
`:n“‘;',;"m"__‘zg:':')‘m
`h““u;‘"f‘,““‘_um“”‘b
`
`
`r(‘3:ner¢;I Information
`
`'
`
`Vendor
`mm
`
`Control'Hoppy Iris‘
`
`7"” "‘
`
`
`
`Bio-Logic Aqua tcchwnogsu
`Natucfs tame Eycmstm
`0 Not an we drop
`O Dnscrvafivi-fvao
`I siocompwbh
`0 Doc: not flood tear film
`0 100% safe and convenient
`I Non-allergenic
`0 No lifting the eyelid
`0 Does not disturbrnakc-up
`I Apply as often as nudcd
`
`Appmval
`
`Inquln
`
`Pmduct Number
`
`composition
`
`Amountper Cube (ml)
`
`Inqulrt
`‘
`,
`Bio-Logs: Aqua“ |s_ an-all-natural. tissun-culture and: water. The
`water‘: purity and mild mineral content make it ideal as a tluur
`culture mudium in biologic laboratory oxptrimcnts and as a
`moisturizing mist forpyu.
`30 mL (1 fluid ounce)
`
`Type of ‘preset->\raIiv¢
`mt P1-kc
`
`presowltivfifrne
`Inquire
`
`Related content
`f'.Z"""""""""""“i
`5 vvuaau-aui
`
`
`
`
`
`
`
`!
`55*’
`
`V4»,,
`
`

`
`
`
`'i “W “W
`.;;o.a;..’; Descriptioit ‘' "
`NATURES TEARSCB is an all-natural moisturizing must for the eyes developed with the consulting
`assistance of Dr. William Mathers, from Oregon Health Sciences University's Casey Eye Institute. Dr.
`Mathers‘ study of NATURE‘S TEARSGI (2000) and dry eye patients showed. on average, that the mist
`doubled the moisture volume of the eyes‘ tear film without disrupting the tear film's delicate structure.
`Contact lens wearers were the most enthusiastic. The mist creates a microvenvironment of pure, all-
`natural, unpolluted, pli correct humidity around the face.
`
`The NATURE'S TEARSO pharmaceutical bottling process meets applicable government and industry
`clean room standards. The water is naturally pure, certified sterile and contaminant-free as it emerges
`from the around. Clean room standards assure that no contamination occurs during the bottling
`process. The company has established additional procedures to assure sterility without altering the
`water‘: mineral content. 8io~Loqic Aquaflvl Technologies is the first bottled water company to globally
`specialize in fiesuevwlwre grade medical water battled to pharmaceutical standards.
`
`The Bio-Logic Aquam Technologies objective is to educate the public about dry eye symptoms, the
`many environmental threats to visual health and the need to naturally replace lost eye moisture. Now,
`with just a mist to the face, you can create a micro-environment of clean, natural, pH curred humidity
`around your eyes and face that restores lost moisture in the eyes‘ tear film and on the skin of the
`eyelids and face. NATURE‘S TEARSQ is easily carried. easily applied and cannot be over-applied.
`
`A
`
`, uenaoscov
`‘s. uuvumi & "“"°
`
`tender cantact‘I_nfo»rrriation
`
`N
`
`I
`
`Customer Slflllcll (eon) 307-0670
`
`Web sital httpxIluvw.naturutaars.com
`
`li0TE2 Medcompare disclaims any information on this site. The information found on Medcemoara (Druo
`Guide, Product Listings and otherwise) is Intended for use by medlcal professionals. This information It not
`Intended to replace the information, advice or instructions from a medical doctor. mice information is
`approximate list price and actual prices may vary.
`
`£m£\&El lE2&lE9£fil
`&flmslmmumlmml£m&l
`
`Cardiovascular I Neurological ; Diagnostics 1 Ophthalmology 1 Urology | Orthopedics 3 General Surgery lAasthetlcs VISIT OUR SISTER $lYES:
`
`searching rot me science products? visit | searching tor dental 9xoduus‘.'V1sItmm
`
`eztour Mr.-.d«;c:m_:~ase 3 »*ui=»'e.ril.:srlr_: me i Fr»:-3-lat £.e:e-grmezs I 5'.lfs's?‘,*;’ and fr.-amis I lfitmtarl 132'; Help 1 Power.» Form zlrlcezoenser 8. Term; of use
`Ccpyriuhtfi 2003-2007 Medcomparmccm. All rights reserved.
`
`
`
`
`
`

`
`
`A Cutting-edge Discovery
`
`
`
`|"|
`
`0104!
`
`totfififltliifi {(3 £536"
`
`Eye Mist:
`
`._U .'.‘.§§I§?§fl9.'.'19..P.'.'¥.§¥§.......................................... ..
`
`‘ Recent discoveries by Bio-Logic Aqua Research.
`Recent discoveries by Bio-Logic Aqua Research regarding the causes of
`. dehydrated and irritated eyes (dry eye) led to the development of the first all-
`natural, all-water, pH balanced mist product for eye moisturizing. For
`» maximum benefit, the eye mist must be correctly applied.
`
`Benefits of ocular misting.
`
`o instantly soothes dry irritated eyes.
`0 Convenient and easy to apply (even ifyour hand is unsteady).
`o No touching of eyelids, tilting back of head or aiming of dropper.
`o Misting supplies only what eyes need
`0 Does not flood ocular tear film or interfere with tear film structure.
`0 Moisturizes contact lenses without removing lenses.
`0 soothes computer eye strain (also called "Computer Vision
`Syndrome" or CVS).
`ht» nab-J.‘6Gou-u- «share-.-.5.--sin uvau-.a.nu-92-u-.~ Auvurnv-.A"anu-O-In
`
`Eye Care‘, News -
`
`
`
`
`'x.‘~:~\e,~«
`
`

`
`o No additives, chemicals, preservatives or propellants,
`0 Will not smudge eye makeup,
`0 May also be used as an emergency eye wash.
`
`correct application.
`The most common error is attempting to apply the mist as though itwas
`an eye drop. by aiming it directly into the eyes. This can flood the eyes and
`= negate some or the benefit. The objective is to create a swirl or moisture
`' around the face. like humid air, from which the eyes absorb as much as they
`' need. Brief blinking is OK.
`
`0 With eyes open, point nozzle of mist canister at side of face next to
`eyes (if you point the nozzle directly atthe eyes, there could be a reflex
`to pull away and close the eyes).
`o F’l’6SS top OT C8l'1lS[6I' I0 release mist.
`0 Move mist canister across face, 8 to 12 inches from eyes, in a one-to-
`two-second sweep. Do not mist directly into eyes.
`
`As an emergency eye wash (for eye irritation from dust, fumes, smoke or
`a small particles), hold eyelids open. lean forward (with yourwaist in an “L" and
`looking atthe ground), and spray entire contents of mist canister back and
`forth directly into the eyes, from about three inches away This is an
`emergency measure only, when no other eye irrigation method is available. It
`I should not replace officially recommended first aid procedures.
`
`.
`
`Single Bcwo or
`Nntixrls Tears.
`L‘ 37.95
`
`y
`
`3 1
`
`_
`
`1
`
`T'*£?’
`'*
`,
`~
`';i
`
`FREE sHlPPlNGl
`“ wlneaoxar
`COMIIHI 2- ‘ 02.
`“flu,” Tan‘
`
`'
`
`-
`
`§;l_f;§5_.,§§~ ¢~iE'jCll,JT . r:r'i:~iN*r v
`.
`L. ’
`‘Ii
`
`

`
`
`
`
`@631 @ E9]
`@@mm
` Teehnické specifikace virrobku:
`
`AROMEDICA
`Internet retailing oi natural pharma cosmetic, aromatherapy and {need supplemenzs
`
`Eye Area Care
`Aromedico > Dharmacoutical bio cosmetic 3 Eye Area Care
`
`
`
`
`
`Refresher A prevents buring and itching of eyes
`
`I ask
`
`I odulat cmallom n data: no product
`
`
`
` Goods catalogue
`
`
`
`
`
`
`
`o Aromatherapy
`6 Pharmaceutical bio
`cosmetic
`D Acne and
`lnfiarnmation
`0 Blood vessel and
`lymphatic system
`0 Body Care
`3 Body fat reduction,
`Body toning, Cetlulite
`6 Eye Area Care
`0 Hair Care
`9 Hands and Feet Care
`6 Lips and Nose Care
`9 Massages,
`Physiotherapy
`o Muswlar~skeleteI
`system, pain
`0 Products for kids
`6 Relaxation and Stress
`6 Respirsbory System
`0 Sin Problems
`9 Skin Care
`9 Soaps
`0 Teeth and Mouth Care
`6 Food supp|arnents ‘Good
`health”
`6 Intimata hygiene
`
`Division by effect
`-
`-
`..
`“‘.““”“"‘“‘“““““
`
`
`
`Type ofcontents
`Volume
`
`voda
`50 ml
`
`Date of delivery: 3_g_n_z
`Price: 153,- CZK
`
`
`
`089-er nmductsku fifvls éecfiioni .7:-. .<.2?!!.-rs>r°..¢.I.-av. !"..sh'sTs-.‘9-.99rv.=T .:
`3 ’ éomposition
`interrogation / answerback M
`
`15.1.. ..L —.- um- -——I-O.
`....-~.—uL- I.-.~l..— -..J lA..I.l._ .‘ —. --
`
`‘I
`
`

`
`
`
`Product description: Refresher eye mist - prevents boring and itching of eyes
`guarantee time 24 Months
`
`This exceptions! product, in combination with eye gel, refreshes the eyes, prevents burning
`and itching sensation In the eyes (good for drivers, computer users, allergies etc.) it is
`made of a special mineral water ll sane containing a number of minerals, namely bivalent
`iron. Apply this fine mistto closed eyes and rest for a little while. other effective
`substances: Dead Sea salts, mallow extract, chamomile essential oils, eye bright
`(Euphrasia rosboriana), fennel seeds essential oils, aloe vera. Contains the maximum
`amount of effective substances and anlv a necessary minute amounts of preservatives.
`
`
`
`
`
`DD
`
`0 Cardio-vascular
`6 Lips and nose
`0 Complexion
`6 Muscular-skeletal
`svstem.Dain
`0 Stomach, guts, dioesti
`0 Energy
`0 Skin care
`0 Respiratory system
`5 Skin problems
`9 Mair care
`0 Hands and feet care
`6 Bath and massage
`0 Stress, relaxation,
`comfort
`9 Products for kid:
`0 none and inflammation
`6 Weight-loss, cellulite
`0 Personal hygiene
`9 Eye care
`I Vacation, leaeure time
`0 Immunity boost
`0 Complex care
`6 Teeth and mouth care
`
`."‘.".‘i'T'.°""
`Zdravé~v92iva:nMatiW 4 “ WW fl
`
`
`
`
` x «item ii;
`
`
`Jednou meslbwi vim budeme
`
`
`s; O Zfiéasmete se na§I
`0
`soutefe o hodnotne
`resflat novinlw
`U 13
`z arornaturapin. inforrnace
`
`1'
`
`o slevich a soutiiich.
`‘E ceny. Kaidfi meslc
`vyhlasujema viherce.
`9&8
`£1
`
`
`2
`
`
`
`
`
`
`
`Cream with Myrrh for oily skin. The
`
`cream has the same effects as live
`balm, but it is suitable for application
`,3 during the day. It creates a velvety
`‘ surface on the skin, and
`
`,
`
`"‘
`
`v
`
`All rights reserved Aromudlcmct
`
`

`
`
`
`
`
`Clinical Research & Development
`
` ORA
`
`j
`
`..
`
`Media : Taking steps Toward Better Compliance
`
`Date: Wednesday, February 15, 2006
`
`
`
`A
`5
`
`.h?..§t,e?§.??9.§v99s§§........
`:..9st22e?=.s..9,9xsrr:§nss
`
`Author: Mark B. Abelson, M.0.,‘Gail Torkildsen, M.D., Kate l-“ink
`
`Source: Review of Ophthalmology
`
`
`
`Have you ever had a patient who didn't respond as expected to a prostaglandin analog,
`or someone who had an unusual degree of inflammation after cataract surgery even
`after you prescribed an appropriate anti-inflammatory? It may have been because of the
`patients lack of compliance. Many patiens are reluctant to admit to missed doses or
`trouble with medication instillation, which makes it more difficult to determine how
`compliant they are or why they’re experiencing problems. In this article, wail take a look
`at themain obstacles to compliance with eye drops, and steps that both industry and
`physioans are taking to overcome them.
`
`
`
`
`
`ways to Enhance Compliance
`
`One study revealed that 69 percent of patients taking eye drops who experienced
`problems in drop administration would not admit this to their doctors, even if asked.‘
`Such reticence is a good reason for eye-care practitioners toprovide every form of help
`possible during the patient’s brief in—office time to facilitate compliance. Once a diagnosis
`has been made and the need for treatment established, the challenge of aixually
`making sure the patient takes an ophthalmic medication involves more than meets the
`eye: First, we must help get the medication into patients’ hands; second, they must
`remember to take it; third, they need to be able to successfully administer the eye drop;
`and finally, the overall process must be made as simple and convenient as possible.
`
`Getting the Medication into Patients’ Hands
`
`Getting a patientto fill aprescription and purchase the needed ophthalmic drug can be
`a challenge in itself. its important to educate the patient about the need for the
`medication and how to use it, and equally important to take the time to make sure the
`patient understands the handling, storage and administration of the drops as well as
`what results to expect. Using visual aids, fact sheets and other educational material can .
`help improve compliance, as can ensuring patients receive information in their own
`language, if its not English.
`
`If patients understand that the prescribed medication is important or crucial to their
`health, this can help provide the motivation they need to fill the prescription. However,
`even this incentive may